Top 5 Performing Stocks To Buy For 2014

Although investors have little news to work with today, the markets are moving to never-before-seen levels today. As of 12:50 p.m. EDT the Dow Jones Industrial Average (DJINDICES: ^DJI  ) is up by 83 points, or 0.55%, to 15,174. But the S&P 500 is the best-performing index, up 0.83%, while the NASDAQ has been lifted by 0.68%.

Let's briefly take a look at a few of the stocks missing today's rally.

Shares of Intel (NASDAQ: INTC  ) are down further today after falling 1.35% yesterday, thanks to a few discouraging comments about the long-term health of the business by analysts at Bernstein Research. So far today shares have fallen 0.8% as investors consider the warning signs and weigh the odds that Intel can overcome the number of hurdles it is facing. With personal-computer sales dramatically slowing, the company will continue to see revenue decline at a time when Intel will need to invest heavily in research and development in order to compete in the mobile-chip industry. The Bernstein analyst noted yesterday that the company may experience a cash flow problem in the coming months, and I agree.

Top 5 Performing Stocks To Buy For 2014: Lorillard Inc(LO)

Lorillard, Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes in the United States. The company offers 43 different product offerings under the Newport, Kent, True, Maverick, and Old Gold brand names. Lorillard, Inc. sells its products primarily to wholesale distributors, who in turn service retail outlets, chain store organizations, and government agencies, including the United States? Armed Forces. The company was founded in 1760 and is headquartered in Greensboro, North Carolina.

Advisors' Opinion:

• [By Maxx Chatsko]

  However, you would be hard-pressed to find any connection between falling smoking prevalence and share performance at Reynolds American (NYSE: RAI  ) , Lorriland (NYSE: LO  ) , Phillip Morris (NYSE: PM  ) , and Altria (NYSE: MO  ) . These companies are some of the best performers in the past decade. In fact, Altria is the best-performing stock of the last half-century!

• [By WWW.DAILYFINANCE.COM]

  The industry started by selling e-cigarettes on the Internet and at shopping-mall kiosks. It has rocketed from thousands of users in 2006 to several million worldwide who have more than 200 brands to choose from. Some e-cigarettes are stocked in prime selling space at the front of convenience-store and gas-station counters -- real estate forbidden to the devices' old-fashioned cousins. Analysts estimate sales of e-cigarettes could reach $2 billion by the end of the year. Some say the use of e-cigarettes could pass that of traditional cigarettes in the next decade. Tobacco company executives have even noted that e-cigarettes are already eating into traditional cigarette sales. The debate over marketing tactics is intensifying as the nation's largest tobacco companies roll out their own e-cigarettes in a push to diversify beyond their traditional business. People are smoking fewer cigarettes in the face of tax hikes, smoking bans, health concerns and social stigma, though higher prices have helped protect cigarette revenue. Companies like NJOY and Blu Ecigs are advertising on TV, forbidden for cigarettes for more than 40 years. LOGIC has placed mobile billboards on taxis in New York City. Swisher International Inc., maker of Swisher Sweets cigars, is sponsoring race cars promoting its e-Swisher electronic cigarettes and cigars and has a two-year deal to become the official e-cigarette of the World Series of Poker. Blu, which was acquired by No. 3 U.S. tobacco company Lorillard (LO) last year, also has sponsored an Indy car and the 2013 Bonnaroo music festival, and its website features a cartoon character nicknamed "Mr. Cool" boasting the benefits of its e-cigarette - evoking the days of Joe Camel. Decades ago, celebrities like actor Spencer Tracy, baseball player Joe DiMaggio and even future President Ronald Reagan shilled for brands like Lucky Strike and Chesterfield. Now, NJOY features rocker Courtney Love in an expletive-laced online ad and counts singer B

• [By gurujx]

  Lorillard (LO): Executive VP and CFO David Taylor Sold 250,069 Shares

  Executive VP and CFO David Taylor sold 250,069 shares of LO stock on Oct. 25 at the average price of $49.44. David H. Taylor owns at least 97,296 shares after this. The price of the stock has increased by 3.94% since.

• [By Dan Caplinger]

  As I observed earlier this week, the entire cigarette industry has been under siege from regulatory and public health authorities. Altria's rivals Reynolds American (NYSE: RAI  ) and Lorillard (NYSE: LO  ) were able to defeat an FDA proposal to force them to show graphic warnings on cigarette packs, but between negative ad campaigns and new attempts to eliminate tobacco display cases in New York City stores, Altria isn't getting any help in fighting a long-term trend of declining U.S. cigarette volume.

Top 5 Performing Stocks To Buy For 2014: China Electronics Corporation Holdings Co Ltd (85)

China Electronics Corporation Holdings Company Limited is an investment holding company. The Company, through its subsidiaries, is engaged in design, research and development and sale of integrated circuits. The Company�� integrated circuits design business consists of the design of integrated circuits chips and the development of application system. Its products are used in smart cards, such as identity cards, social security cards, telecommunications cards and electric cards. Its products are also applied in wireless local area networks (WLAN). During the year ended December 31, 2011, the Company obtained 17 new patents, and registered another 16 computer software copyrights and 11 integrated circuits layout designs. Its subsidiaries include CEC Integrated Circuit (Beijing) Co., Ltd, CEC Huada Electronic Design Co., Ltd and others.

Top 5 Stocks To Watch Right Now: Golden Dawn Minerals Inc (GOM.V)

Golden Dawn Minerals Inc., a junior resource exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada. The company primarily explores for gold, copper, silver, lead, zinc, and base and precious metal deposits. It has interest in the Greenwood project consisting of three contiguous properties located in the Greenwood Mining District of British Columbia; and the Kirkland Lake project comprising three blocks of claims covering an area of 1,896 hectares and is located in South-southeast of Kirkland Lake, Ontario. The company was founded in 2004 and is based in Vancouver, Canada.

Top 5 Performing Stocks To Buy For 2014: Origin Energy Ltd(ORG.AX)

Origin Energy Limited, together with its subsidiaries, engages in the oil and gas exploration and production primarily in Australia and New Zealand. The company also involves in the generation of electricity, wholesale and retail sale of electricity and gas. It owns interests in the BassGas project in Victoria; the Kupe Gas project in New Zealand; the Otway Gas project in Victoria; and coal seam gas fields at Spring Gully, Fairview, and Peat in the Bowen Basin in central Queensland. The company generates gas-fired and wind power; holds interests in co-generation plants that supply electricity and steam under long-term contracts; and retails electricity, natural gas, LP gas, and other energy-related products and services. It serves approximately 4.6 million energy customers in Australia and the Pacific; and 520,000 electricity customers and 75,000 gas customers in New Zealand. Origin Energy Limited is headquartered in Sydney, Australia.

Top 5 Performing Stocks To Buy For 2014: Ventrus Biosciences Inc.(VTUS)

Ventrus Biosciences, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, primarily hemorrhoidal disease, anal fissures, and fecal incontinence. It is developing three late-stage product candidates, including Iferanserin ointment (VEN 309) for the topical treatment of symptomatic internal hemorrhoids; Diltiazem cream (VEN 307), a topical treatment for the relief of pain associated with anal fissures; and Phenylephrine gel (VEN 308) for the treatment of fecal incontinence associated with ileal pouch anal anastomosis, an FDA orphan indication. The company was formerly known as South Island Biosciences, Inc. and changed its name to Ventrus Biosciences, Inc. in April 2007. Ventrus BioSciences, Inc. was founded in 2005 and is based in New York, New York.